End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.760 NZD | -0.21% |
|
-1.24% | +13.33% |
Jun. 05 | New Zealand's Synlait Milk provides milk price forecast for 2025/26 season | RE |
Jun. 04 | Fonterra's New Season Milk Price Forecast Reflects 'Considerable' Uncertainty | MT |
Fiscal Period: July | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 20.28B | 20.56B | 22.95B | 24.58B | 22.82B | |||||
Total Revenues | 20.28B | 20.56B | 22.95B | 24.58B | 22.82B | |||||
Cost of Goods Sold, Total | 17.24B | 17.58B | 19.74B | 20.4B | 19B | |||||
Gross Profit | 3.05B | 2.98B | 3.22B | 4.18B | 3.82B | |||||
Selling General & Admin Expenses, Total | 1.87B | 1.86B | 1.93B | 1.82B | 1.98B | |||||
Depreciation & Amortization - (IS) | - | - | - | 180M | 187M | |||||
Other Operating Expenses | 307M | 257M | 58M | 181M | 73M | |||||
Other Operating Expenses, Total | 2.18B | 2.12B | 1.99B | 2.18B | 2.24B | |||||
Operating Income | 871M | 866M | 1.23B | 2B | 1.58B | |||||
Interest Expense, Total | -317M | -261M | -208M | -256M | -199M | |||||
Interest And Investment Income | 13M | 9M | 14M | 22M | 12M | |||||
Net Interest Expenses | -304M | -252M | -194M | -234M | -187M | |||||
Income (Loss) On Equity Invest. | -6M | 5M | 10M | - | - | |||||
Currency Exchange Gains (Loss) | -8M | 25M | -182M | - | 16M | |||||
Other Non Operating Income (Expenses) | - | - | - | 23M | 30M | |||||
EBT, Excl. Unusual Items | 553M | 644M | 864M | 1.79B | 1.44B | |||||
Restructuring Charges | 78M | -9M | - | - | - | |||||
Impairment of Goodwill | - | - | - | -121M | - | |||||
Gain (Loss) On Sale Of Investments | 402M | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | -55M | - | -34M | -127M | -34M | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 978M | 635M | 830M | 1.54B | 1.4B | |||||
Income Tax Expense | 175M | 103M | 169M | 303M | 235M | |||||
Earnings From Continuing Operations | 803M | 532M | 661M | 1.24B | 1.17B | |||||
Earnings Of Discontinued Operations | -144M | 67M | -78M | 336M | -40M | |||||
Net Income to Company | 659M | 599M | 583M | 1.58B | 1.13B | |||||
Minority Interest | 27M | -21M | 1M | - | - | |||||
Net Income - (IS) | 686M | 578M | 584M | 1.58B | 1.13B | |||||
Net Income to Common Incl Extra Items | 686M | 578M | 584M | 1.58B | 1.13B | |||||
Net Income to Common Excl. Extra Items | 830M | 511M | 662M | 1.24B | 1.17B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.43 | 0.36 | 0.36 | 0.98 | 0.7 | |||||
Basic EPS - Continuing Operations | 0.51 | 0.32 | 0.41 | 0.77 | 0.73 | |||||
Basic Weighted Average Shares Outstanding | 1.61B | 1.61B | 1.61B | 1.61B | 1.61B | |||||
Net EPS - Diluted | 0.43 | 0.36 | 0.36 | 0.98 | 0.7 | |||||
Diluted EPS - Continuing Operations | 0.51 | 0.32 | 0.41 | 0.77 | 0.73 | |||||
Diluted Weighted Average Shares Outstanding | 1.61B | 1.61B | 1.61B | 1.61B | 1.61B | |||||
Normalized Basic EPS | 0.23 | 0.24 | 0.34 | 0.7 | 0.56 | |||||
Normalized Diluted EPS | 0.23 | 0.24 | 0.34 | 0.7 | 0.56 | |||||
Dividend Per Share | 0.05 | 0.2 | 0.2 | 0.48 | 0.4 | |||||
Payout Ratio | - | 27.16 | 55.31 | 25.55 | 78.37 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.3B | 1.3B | 1.67B | 2.48B | 2.03B | |||||
EBITA | 873M | 868M | 1.23B | 2B | 1.58B | |||||
EBIT | 871M | 866M | 1.23B | 2B | 1.58B | |||||
EBITDAR | 1.32B | 1.33B | 1.7B | - | - | |||||
Effective Tax Rate - (Ratio) | 17.89 | 16.22 | 20.36 | 19.62 | 16.75 | |||||
Total Current Taxes | 98M | 94M | 109M | 95M | 113M | |||||
Total Deferred Taxes | 77M | 9M | 60M | 208M | 122M | |||||
Normalized Net Income | 373M | 382M | 541M | 1.12B | 898M | |||||
Interest Capitalized | 3M | 5M | 7M | - | - | |||||
Interest on Long-Term Debt | - | 17M | 13M | 13M | 12M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | 219M | 240M | |||||
Selling and Marketing Expenses | 1.03B | 1.05B | 1.1B | 482M | 508M | |||||
General and Administrative Expenses | 835M | 811M | 831M | 372M | 491M | |||||
Research And Development Expense From Footnotes | 98M | 110M | 115M | 119M | 107M | |||||
Net Rental Expense, Total | 21M | 23M | 24M | - | - | |||||
Imputed Operating Lease Interest Expense | 8.49M | 8.77M | 7.95M | - | - | |||||
Imputed Operating Lease Depreciation | 12.51M | 14.23M | 16.05M | - | - |
Select your edition
All financial news and data tailored to specific country editions